Details for 2011184000

Up to date per 11.05.2026

Actions

Title / Product Name

1,2-Disubstituierte 4-Benzylamino-pyrrolidin-Derivate als CETP-Inhibitoren verwendbar für die Behandlung von Krankheiten wie Hyperlipidämie oder Arteriosklerose

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2011184000

EP Publication Number

2404901

E-Number

613145

Language

PCT Number

Publication Date

11.01.2012 A

22.05.2013 B1

Registration Date

22.05.2013

AT Publication Date

15.06.2013

Application Date

01.12.2008

Registration Number

Priorities

03.12.2007

991891 P

IPC

C07D 207/14 20060101AFI20111129BHEP

Maximum Duration of Protection

01.12.2028

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

Mogi, Muneto70 Hope Avenue 603 Waltham, MA Massachusetts 02453US

Kawanami, ToshioOne Emerson Place 16L Boston, MA Massachusetts 02114US

Yamada, Ken4 Emerson Place 711 Boston, MA Massachusetts 02114US

Yasoshima, Kayo285 Third street 415 Cambridge, MA Massachusetts 02142US

Imase, Hidetomo30 Cambridge Park Dr. 4137 Cambridge, MA Massachusetts 02140US

Miyake, TakahiroGrand Seed Emile Room 102 2-9-8 Kumochi-chou Chuou-ku Kobe-shi, Hyogo 651-0056JP

Ohmori, Osamu685-1-B4 Mifuku Izunokuni-shi, Shizuoka 410-2321JP